Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities
about
Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part III - convergence toward clinical trialsMedicinal cannabisCellular Mechanisms of Action of Drug Abuse on Olfactory NeuronsSmall Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and DevelopmentEndogenous vs Exogenous Allosteric Modulators in GPCRs: A dispute for shuttling CB1 among different membrane microenvironments.The endocannabinoid system as a potential therapeutic target for pain modulationElevating endocannabinoid levels: pharmacological strategies and potential therapeutic applicationsFocus on cannabinoids and synthetic cannabinoids.Role of Cannabinoids in Gastrointestinal Mucosal Defense and InflammationA restricted population of CB1 cannabinoid receptors with neuroprotective activityAcute Δ(9)-tetrahydrocannabinol blocks gastric hemorrhages induced by the nonsteroidal anti-inflammatory drug diclofenac sodium in miceDiarylureas as allosteric modulators of the cannabinoid CB1 receptor: structure-activity relationship studies on 1-(4-chlorophenyl)-3-{3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl}urea (PSNCBAM-1).Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawalColon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid.Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling.The Pharmacological Basis of Cannabis Therapy for Epilepsy.CB2-selective cannabinoid receptor ligands: synthesis, pharmacological evaluation, and molecular modeling investigation of 1,8-Naphthyridin-2(1H)-one-3-carboxamides.Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor.Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotectionEfficacy, Tolerability, and Safety of Cannabinoid Treatments in the Rheumatic Diseases: A Systematic Review of Randomized Controlled Trials.Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Δ9-TetrahydrocannabinolDronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns.Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis.Molecular-interaction and signaling profiles of AM3677, a novel covalent agonist selective for the cannabinoid 1 receptor.Dissociation of the pharmacological effects of THC by mTOR blockade.Combined Treatment with Morphine and Δ9-Tetrahydrocannabinol in Rhesus Monkeys: Antinociceptive Tolerance and Withdrawal.Modulating the endocannabinoid system in human health and disease--successes and failuresHeterogeneous presynaptic distribution of monoacylglycerol lipase, a multipotent regulator of nociceptive circuits in the mouse spinal cord.Involvement of the endocannabinoid system in osteoarthritis pain.Interplay between synaptic endocannabinoid signaling and metaplasticity in neuronal circuit function and dysfunction.Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.The endocannabinoid system and appetite: relevance for food reward.Astrocytes in endocannabinoid signalling.Endocannabinoids, related compounds and their metabolic routes.Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials.Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….Medical use of cannabis: an addiction medicine perspective.Cannabis, Cannabinoids, and Cerebral Metabolism: Potential Applications in Stroke and Disorders of the Central Nervous System.The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain.Annual Research Review: On the developmental neuropsychology of substance use disorders.
P2860
Q24600527-F121A4CF-8A03-4D6B-AA28-F973C4D8F661Q26769626-BBB50F65-1376-4D5C-9B2C-01BEE44FC902Q26772009-2F76B181-3D71-4F54-B416-6D75A3C96A89Q26776241-BB872311-2698-46A1-AE53-75285EC685FFQ27308091-9434C839-CAFE-4C12-B226-F0248D0CB33DQ28247621-E507FD32-38CA-4D92-A24E-E41B293BB1DFQ28300390-E22816BC-3FE9-4616-8A76-54DEA7ABD614Q30241053-BEE8B59A-07A2-4493-8D85-B07B0223E1C5Q30357558-6173B240-A3AD-46C6-A526-E5899AC12BFFQ33730578-8D0473FE-F8B9-4247-8289-7AEFC661151EQ33739530-3416D2E3-8717-43C5-8A1C-02329BB800FEQ34243225-102350AB-15CC-4985-9533-781F13555094Q34403197-9976C005-6584-4680-809D-128BBDE8BE49Q34441093-E47047CB-0DAD-4A17-A39E-FA4C1BE2B868Q34452582-A345806D-E829-49D8-B033-8978B01FC803Q34509920-B97DDE97-362E-48E1-802A-9255AA4E5155Q34525138-A74A74A7-5284-4B20-AAC4-1BADC2A8E3DCQ34545629-97F8CF7A-0284-4EA4-89D7-E722EBC5981AQ35499568-AD75436D-2480-4FCA-8A10-FCED48046DA0Q35835342-427DB888-320D-40C4-9351-60E088D46FB8Q35860227-F9D0C6E7-19F5-41D7-9D79-B3C7CF8A6582Q35896078-5F25B941-4083-44A7-B0F8-506F77A91CF8Q36157623-D83B8980-ECA8-4099-863E-E19A04B2E5F5Q36720905-F52705B3-0234-45BB-8DF3-5D747F5DCF5CQ36850581-0E85D731-6834-40F2-A7CA-C06E6E6FD261Q36852565-F247FC76-E3C2-4B88-9ECD-976CC135241DQ36933683-6391862C-0750-46FB-BA57-AD9AF630661CQ37691232-804BEE87-91AA-4FA1-9BAA-2BEF28FC3892Q38185076-29137B5A-8FD3-4006-A7FA-AFA8A8B020CAQ38203030-FD450963-52FF-476A-BCCA-4B02923D644CQ38212376-23115A44-E63D-42E2-AB15-5D2B0415B2EBQ38220568-4A3FF1B3-82D9-4630-A5A7-FCE28038AE97Q38250029-DBC7E6B1-3310-4028-A694-FF826B7F6C8AQ38262964-C58FA50B-BED2-4415-A5FA-AAF64D7EC152Q38386497-0F72BEE8-A188-4AF5-9C41-9691CB11AC0DQ38503842-536EDB69-5DCE-4A0D-A621-CBB7942FC80FQ38522939-0D3C3BB8-06D2-4D59-9EED-6D4A6F5C46C2Q38560061-732B6F52-A01F-4D0C-8E8D-F382399358F9Q38600704-1CD6B06B-A406-413B-9B4A-BC1647319DB3Q38738677-4FDDF49F-5964-4656-8C7B-05883127049F
P2860
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Targeting the endocannabinoid ...... and therapeutic possibilities
@ast
Targeting the endocannabinoid ...... and therapeutic possibilities
@en
Targeting the endocannabinoid ...... and therapeutic possibilities
@nl
type
label
Targeting the endocannabinoid ...... and therapeutic possibilities
@ast
Targeting the endocannabinoid ...... and therapeutic possibilities
@en
Targeting the endocannabinoid ...... and therapeutic possibilities
@nl
prefLabel
Targeting the endocannabinoid ...... and therapeutic possibilities
@ast
Targeting the endocannabinoid ...... and therapeutic possibilities
@en
Targeting the endocannabinoid ...... and therapeutic possibilities
@nl
P2860
P921
P3181
P356
P1476
Targeting the endocannabinoid ...... and therapeutic possibilities
@en
P2093
Roger G Pertwee
P2860
P304
P3181
P356
10.1098/RSTB.2011.0381
P407
P577
2012-12-05T00:00:00Z